Download Sample
Add to CartAortic Aneurysm Market
By Type;
Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA)By Product;
Stent Grafts, Catheters and OthersBy Treatment;
Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR)By End User;
Hospitals And Clinics, Ambulatory Surgery Centers (ASCs) and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Aortic Aneurysm Market Overview
Aortic Aneurysm Market (USD Million)
Aortic Aneurysm Market was valued at USD 2,690.64 million in the year 2024. The size of this market is expected to increase to USD 4,671.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.2%.
Aortic Aneurysm Market
*Market size in USD million
CAGR 8.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 8.2 % |
| Market Size (2024) | USD 2,690.64 Million |
| Market Size (2031) | USD 4,671.40 Million |
| Market Concentration | Medium |
| Report Pages | 314 |
Major Players
- Medtronic Plc
- Cook Medical
- Terumo Medical Corporation
- Microport Scientific Corporation
- MAQUET Holding B.V. & Co. KG
- Endologix, Inc.
- W. L. Gore & Associates
- Lombard Medical Limited
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Aortic Aneurysm Market
Fragmented - Highly competitive market without dominant players
The Aortic Aneurysm Market is advancing with accelerated technological advancements, with more than 60% of development centering on enhanced endovascular graft designs and stent systems. These advanced devices improve efficacy, reduce procedural risks, and support precise aneurysm repair, contributing to sustained growth and broader adoption in vascular interventions.
Delivery System Innovation Enhancing Minimally Invasive Procedures
More than 50% of R&D is devoted to innovation in delivery mechanisms—like flexible fenestrated grafts, branched configurations, and catheter robotics. These delivery enhancements support safer, less-invasive procedures and faster recovery rates. Focused device engineering is strengthening the market’s future outlook and enabling steady growth in surgical applications.
Mergers Enhancing Integrated Device Ecosystems
Nearly 35% of the market’s progress is attributed to merger deals connecting device manufacturing, imaging software, and analytics platforms. These consolidations enhance technological capabilities, integrate data-driven development, and drive scalable production. The outcome is fortified infrastructure enabling accelerated expansion of comprehensive aneurysm solutions.
AI‑Enabled Follow‑Up Tools Improving Outcome Monitoring
With over 50% of providers implementing AI-based tracking and surveillance platforms, the market is moving toward intelligent graft monitoring and complication prediction. These technologies deliver real-time post-procedural insights, optimizing patient care. The fusion of digital tools and device innovation highlights the influence of technological advancements, securing enduring growth and a forward-focused future outlook.
Aortic Aneurysm Market Recent Developments
- In January 2022, Cardiovascular Systems, Inc. along with OrbusNeich Medical Company Ltd (OrbusNeich), received approval from the United States Food and Drug Administration for OrbusNeich's Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter (Scoreflex NC).
- In January 2022, Humacyte reported preclinical results of a Small-Diameter Human Acellular Vessel (HAV) in Coronary Artery Bypass Grafting.
Aortic Aneurysm Market Segment Analysis
In this report, the Aortic Aneurysm Market has been segmented by Type, Product, Treatment, End User and Geography.
Aortic Aneurysm Market, Segmentation by Type
The Aortic Aneurysm Market has been segmented by Type into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA).
Abdominal Aortic Aneurysm (AAA)
Abdominal aortic aneurysm (AAA) constitutes approximately 70% of the overall aortic aneurysm market. It occurs in the lower portion of the aorta and is strongly linked to risk factors such as age, male gender, and a history of smoking. Increasing adoption of ultrasound screening programs and focus on early detection are driving the segment’s growth.
Thoracic Aortic Aneurysm (TAA)
Thoracic aortic aneurysm (TAA) holds about 30% of the market and affects the upper section of the aorta within the chest. It is often associated with connective tissue disorders, aortic valve abnormalities, or trauma. The availability of advanced imaging technologies like CT and MRI has improved diagnosis and surgical outcomes in this segment.
Aortic Aneurysm Market, Segmentation by Product
The Aortic Aneurysm Market has been segmented by Product into Stent Grafts, Catheters and Others.
Stent Grafts
Stent grafts dominate the product segment, accounting for approximately 65% of the market. These devices are essential in endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) procedures. The rise in minimally invasive surgeries and improved device longevity are key factors fueling growth.
Catheters
Catheters hold around 25% of the market and play a critical role in the delivery of stent grafts and other endovascular tools. Their precision and flexibility are vital for navigating complex vascular anatomies. Continuous technological advancements have enhanced their performance in image-guided procedures.
Others
The ‘Others’ segment contributes nearly 10% and includes products such as guidewires, sheaths, and balloons used during aortic aneurysm interventions. Though smaller in share, this segment benefits from innovations in vascular access tools and growing use in hybrid operating rooms.
Aortic Aneurysm Market, Segmentation by Treatment
The Aortic Aneurysm Market has been segmented by Treatment into Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR).
Endovascular Aneurysm Repair (EVAR)
Endovascular aneurysm repair (EVAR) holds the largest share of the treatment segment, accounting for nearly 70% of the market. This minimally invasive procedure is widely preferred due to shorter recovery times, reduced surgical complications, and its suitability for high-risk patients. Increasing adoption of stent graft systems is further propelling growth.
Open Surgical Repair (OSR)
Open surgical repair (OSR) contributes around 30% of the market and remains critical for patients with complex aneurysms or anatomical constraints not suited for EVAR. Despite being more invasive, OSR offers long-term durability and is still the preferred approach in younger patients or where graft anchoring is challenging.
Aortic Aneurysm Market, Segmentation by End User
The Aortic Aneurysm Market has been segmented by End User into Hospitals And Clinics, Ambulatory Surgery Centers (ASCs) and Others.
Hospitals and Clinics
Hospitals and clinics represent the largest share of the market, accounting for nearly 65%. These settings are equipped with advanced imaging technologies, surgical infrastructure, and emergency care units required for both EVAR and OSR procedures. The growing incidence of aortic aneurysms and emphasis on early intervention continue to drive this segment.
Ambulatory Surgery Centers (ASCs)
Ambulatory surgery centers hold around 25% of the market. ASCs offer minimally invasive procedures with shorter hospital stays and lower costs, making them increasingly popular for elective EVAR treatments. Their role is expanding in regions with a focus on cost-effective care delivery.
Others
The ‘Others’ segment contributes approximately 10% and includes research institutes, mobile surgical units, and military healthcare facilities. These settings support clinical trials, outreach programs, and specialized vascular interventions, particularly in underserved or high-risk regions.
Aortic Aneurysm Market, Segmentation by Geography
In this report, the Aortic Aneurysm Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Aortic Aneurysm Market Share (%), by Geographical Region
North America
North America leads the aortic aneurysm market with a share of approximately 40%. The region benefits from widespread access to advanced surgical technologies, a high prevalence of cardiovascular risk factors, and strong reimbursement support. Growing adoption of endovascular procedures is a key driver of market expansion.
Europe
Europe accounts for nearly 25% of the market, driven by a rising geriatric population and improvements in vascular screening programs. Increasing preference for minimally invasive treatments and supportive healthcare infrastructure contribute to the region’s steady growth in aneurysm repair procedures.
Asia Pacific
Asia Pacific holds around 20% of the global market and is expected to grow at the fastest rate. The region is experiencing rising cases of hypertension and smoking-related vascular conditions, especially in countries like India, China, and Japan. Expanding healthcare access and government awareness campaigns are boosting diagnostics and treatment uptake.
Middle East and Africa
This region contributes about 8% to the aortic aneurysm market. Although limited by infrastructure challenges, increasing investment in healthcare systems and international partnerships are improving access to aneurysm repair technologies in high-risk populations.
Latin America
Latin America holds close to 7% of the market. Countries like Brazil and Mexico are witnessing increased demand due to urban lifestyle changes, a rising incidence of vascular disorders, and improved access to endovascular devices in both public and private healthcare sectors.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Aortic Aneurysm Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Technological Advancements
- Increasing Awareness
-
Rising Healthcare Expenditure: Rising healthcare expenditure is a significant driver influencing the global aortic aneurysm market. As economies grow and populations age, there is an increasing allocation of resources towards healthcare, including diagnostics, treatments, and research related to aortic aneurysms. This trend is particularly pronounced in developed regions where healthcare infrastructure is robust and funding for innovative medical technologies is readily available.
The rising prevalence of aortic aneurysms, coupled with advancements in medical science and technology, necessitates higher healthcare spending. Investment in early detection technologies such as advanced imaging modalities and genetic screening contributes to early intervention, potentially reducing long-term healthcare costs associated with complications like aneurysm rupture. As healthcare systems worldwide strive to enhance patient outcomes and reduce morbidity and mortality rates, the increase in healthcare expenditure underscores a commitment to addressing the challenges posed by aortic aneurysms comprehensively.
Restraints
- High Treatment Costs
- Lack of Skilled Surgeons
- Stringent Regulatory Framework
-
Limited Access to Healthcare: Limited access to healthcare poses a significant restraint in the global management of aortic aneurysms. This issue is particularly acute in underserved regions and among socioeconomically disadvantaged populations, where barriers such as geographic remoteness, inadequate infrastructure, and financial constraints hinder timely access to essential healthcare services. As a result, individuals in these areas may face delays in diagnosis, treatment, and follow-up care for aortic aneurysms, potentially exacerbating health outcomes and increasing the burden of disease.
The consequences of limited access to healthcare are profound, as delayed diagnosis and treatment of aortic aneurysms can lead to higher rates of complications, including aneurysm rupture, which carries a substantial risk of mortality. Efforts to mitigate these disparities include initiatives aimed at improving healthcare infrastructure, expanding access to diagnostic tools and specialist care, and implementing public health programs to raise awareness about the importance of early detection and intervention. Addressing these challenges is crucial to ensuring equitable access to effective treatments and improving outcomes for all individuals affected by aortic aneurysms globally.
Opportunities
- Emerging Markets Expansion
- Development of Minimally Invasive Techniques
- Personalized Medicine Approaches
-
Collaborative Research Initiatives: Collaborative research initiatives play a pivotal role in advancing the understanding and treatment of aortic aneurysms on a global scale. These initiatives typically involve partnerships between healthcare providers, academic institutions, pharmaceutical companies, and research organizations. By pooling expertise, resources, and data, collaborative efforts accelerate the pace of innovation in diagnostics, treatment modalities, and patient care strategies.
Through collaborative research, multidisciplinary teams can explore novel approaches to managing aortic aneurysms, including the development of innovative biomaterials for stent grafts, refinement of imaging technologies for more accurate diagnosis, and exploration of personalized medicine approaches tailored to individual patient needs. Such initiatives foster a synergistic exchange of knowledge and ideas, promoting the translation of scientific discoveries into clinical practice.
Competitive Landscape Analysis
Key players in Global Aortic Aneurysm Market include
- Medtronic Plc
- Cook Medical
- Terumo Medical Corporation
- Microport Scientific Corporation
- MAQUET Holding B.V. & Co. KG
- Endologix, Inc.
- W. L. Gore & Associates
- Lombard Medical Limited
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
- Aortic Aneurysm Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Technological Advancements
- Increasing Awareness
- Rising Healthcare Expenditure
- Restraints
- High Treatment Costs
- Lack of Skilled Surgeons
- Stringent Regulatory Framework
- Limited Access to Healthcare
- Opportunities
- Emerging Markets Expansion
- Development of Minimally Invasive Techniques
- Personalized Medicine Approaches
- Collaborative Research Initiatives
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competiitve Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Aortic Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Aortic Aneurysm Market, By Product, 2021 - 2031 (USD Million)
- Stent Grafts
- Catheters
- Others
- Aortic Aneurysm Market, By Treatment, 2021 - 2031 (USD Million)
- Endovascular Aneurysm Repair (EVAR)
- Open Surgical Repair (OSR)
- Aortic Aneurysm Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Ambulatory Surgery Centers (ASCs)
- Others
- Aortic Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Aortic Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic Plc
- Cook Medical
- Terumo Medical Corporation
- Microport Scientific Corporation
- MAQUET Holding B.V. & Co. KG
- Endologix, Inc.
- W. L. Gore & Associates
- Lombard Medical Limited
- Company Profiles
- Analyst Views
- Future Outlook of the Market